Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
VIA Pharmaceuticals, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
VIA Pharmaceuticals, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Cambridge Acquisition Corp.Listing unverified | AwardD (derivative) | — | SEC | |
Cambridge Acquisition Corp.Listing unverified | AwardD (derivative) | — | SEC | |
Cambridge Acquisition Corp.Listing unverified | Buy | $137.5K | SEC | |
Cambridge Acquisition Corp.Listing unverified | AwardD (derivative) | — | SEC | |
Cambridge Acquisition Corp.Listing unverified | AwardD (derivative) | — | SEC | |
Cambridge Acquisition Corp.Listing unverified | AwardD (derivative) | — | SEC | |
Cambridge Acquisition Corp.Listing unverified | AwardD (derivative) | — | SEC | |
Cambridge Acquisition Corp.Listing unverified | AwardD (derivative) | — | SEC | |
Cambridge Acquisition Corp.Listing unverified | AwardD (derivative) | — | SEC | |
Cambridge Acquisition Corp.Listing unverified | AwardD (derivative) | — | SEC |